Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Both of these biotech stocks could be appealing to income investors.

According to BCC Research, the global agricultural biotechnology market is projected to grow from $91.5 billion in 2026 to ...

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

All that has changed, and if you want to invest in growth away from AI, biotech might be where you want to be. Below, I will attempt to lay out the various macro and policy disruptions that had a ...

Biotech stocks saw sharp moves in Friday's premarket trading, led by gains in Alaunos Therapeutics following a major ...

Recent weakness in US technology shares as investors question heavy AI spending has pushed some capital away from crowded ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it, the ...

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the ...

Biotechnology stocks represent a great opportunity for investors who are fortunate enough to get into the right names at the right time. The biotech stock sector has always been a stellar performer in ...